/HCLC

HCLC Stock - Health-Chem Corporation

Q: What is the analyst price target for HCLC?

Analyst price target information is not currently available for HCLC.

Q: What is HCLC's market cap?

Market capitalization information is not currently available for HCLC.

Healthcare|Medical - Diagnostics & Research|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Jan 2

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for HCLC

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY1996

FY1997

FY2004

FY2005

FY2006

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-26.02

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2006	FY2005	FY2004	FY1997	FY1996
Revenue	$5.94M	$7.59M	$9.19M	$37.70M	$47.60M
Gross Profit	$583,000	$1.14M	$2.94M	$10.90M	$15.70M
Gross Margin	9.8%	15.0%	32.0%	28.9%	33.0%
Operating Income	$2.64M	$2.84M	$25,000	$-3,800,000	$-1,900,000
Net Income	$-1,656,000	$-2,480,000	$9,000	$-3,300,000	$-1,300,000
Net Margin	-27.9%	-32.7%	0.1%	-8.8%	-2.7%
EPS	$-0.14	$-0.22	$0.00	$-0.41	$-0.17

Company Overview

Health-Chem Corporation, through its subsidiary, Transderm Laboratories Corporation, engages in the research, development, manufacture, and marketing of transdermal drug delivery systems in the United States. It offers transdermal nitroglycerin patches used for transdermal relief of the vascular and cardiovascular symptoms related to angina pectoris (chest pain). The company also conducts research and development activities for third parties on a contract basis. Health-Chem Corporation markets its products directly to wholesalers, distributors, retail pharmacy chains, mail order pharmacies, and group purchasing organizations, as well as indirectly to independent pharmacies, managed care organizations, hospitals, nursing homes, and pharmacy benefit management companies. The company was founded in 1970 and is based in Emigsville, Pennsylvania.

Frequently Asked Questions about HCLC

What is HCLC's current stock price?

Health-Chem Corporation (HCLC) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for HCLC?

No analyst price targets are currently available for this stock.

What sector is Health-Chem Corporation in?

Health-Chem Corporation operates in the Healthcare sector, specifically within the Medical - Diagnostics & Research industry. The company is traded on the OTC exchange.

What is HCLC's market cap?

Health-Chem Corporation has a market capitalization of $0.00 billion, making it a small-cap company.

Does HCLC pay dividends?

No, Health-Chem Corporation does not currently pay a dividend to shareholders.